176 related articles for article (PubMed ID: 2354019)
1. [The clinical significance of anti-IgE antibodies in the treatment of allergic rhinopathy].
Loidolt D; Vassella CC; de Weck AL; Stadler BM
Laryngorhinootologie; 1990 May; 69(5):255-9. PubMed ID: 2354019
[TBL] [Abstract][Full Text] [Related]
2. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.
Corne J; Djukanovic R; Thomas L; Warner J; Botta L; Grandordy B; Gygax D; Heusser C; Patalano F; Richardson W; Kilchherr E; Staehelin T; Davis F; Gordon W; Sun L; Liou R; Wang G; Chang TW; Holgate S
J Clin Invest; 1997 Mar; 99(5):879-87. PubMed ID: 9062345
[TBL] [Abstract][Full Text] [Related]
3. [IgE and IgG antibody response in patients with type I allergy to birch pollen].
Rumpold H; Jarolim E; Bonitz W; Tejkl M; Breitenbach M; Scheiner O; Kraft D
Wien Klin Wochenschr; 1989 Feb; 101(3):107-10. PubMed ID: 2922932
[TBL] [Abstract][Full Text] [Related]
4. Anti-IgE for the treatment of allergic rhinitis--and eventually nasal polyps?
Verbruggen K; Van Cauwenberge P; Bachert C
Int Arch Allergy Immunol; 2009; 148(2):87-98. PubMed ID: 18799888
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a combination of anti-IgE and specific immunotherapy for allergic rhinitis and asthma.
Hamelmann E; Rolinck-Werninghaus C; Wahn U; Kopp MV
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():303-13; discussion 313-5. PubMed ID: 20799475
[TBL] [Abstract][Full Text] [Related]
6. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).
Bousquet J; van Cauwenberge P; Aït Khaled N; Bachert C; Baena-Cagnani CE; Bouchard J; Bunnag C; Canonica GW; Carlsen KH; Chen YZ; Cruz AA; Custovic A; Demoly P; Dubakiene R; Durham S; Fokkens W; Howarth P; Kemp J; Kowalski ML; Kvedariene V; Lipworth B; Lockey R; Lund V; Mavale-Manuel S; Meltzer EO; Mullol J; Naclerio R; Nekam K; Ohta K; Papadopoulos N; Passalacqua G; Pawankar R; Popov T; Potter P; Price D; Scadding G; Simons FE; Spicak V; Valovirta E; Wang DY; Yawn B; Yusuf O;
Allergy; 2006 Sep; 61(9):1086-96. PubMed ID: 16918512
[TBL] [Abstract][Full Text] [Related]
8. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
9. [Allergic rhinopathy: diagnosis and current therapy].
Tripodi D; Torchia SL
Clin Ter; 1990 Jul; 134(2):85-94. PubMed ID: 2147615
[TBL] [Abstract][Full Text] [Related]
10. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
11. Effect of specific immunotherapy on IgE immune complexes in seasonal allergic rhinitis.
Rogala B; Jarzab J; Karawajczyk M; Jawor B; Rogala E
Pneumonol Alergol Pol; 1992; 60 Suppl 1():57-62. PubMed ID: 1292849
[No Abstract] [Full Text] [Related]
12. [What is reliable in hyposensitization of IgE-induced diseases? Indications, contraindications, results and side effects].
Fuchs T
Internist (Berl); 1991 Dec; 32(12):721-8. PubMed ID: 1783514
[No Abstract] [Full Text] [Related]
13. [Glutarladehyde-pollen-tyrosine hyposensitization. Course control of therapy using RIST and RAST].
Jarisch R
Hautarzt; 1977 Apr; 28(4):185-7. PubMed ID: 406220
[TBL] [Abstract][Full Text] [Related]
14. [The management of allergic rhinitis (author's transl)].
Lallemant Y; Rigothier G; Gehanno P
Ann Otolaryngol Chir Cervicofac; 1980; 97(10-11):857-72. PubMed ID: 7212535
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.
Di Lorenzo G; Mansueto P; Pacor ML; Rizzo M; Castello F; Martinelli N; Ditta V; Lo Bianco C; Leto-Barone MS; D'Alcamo A; Di Fede G; Rini GB; Ditto AM
J Allergy Clin Immunol; 2009 May; 123(5):1103-10, 1110.e1-4. PubMed ID: 19356792
[TBL] [Abstract][Full Text] [Related]
16. [Hyposensitization and antihistamines in the treatment of bronchial and allergic rhinitis].
Plavsić Z; Popovac D; Mandić D
Plucne Bolesti; 1991; 43(1-2):21-5. PubMed ID: 1766980
[TBL] [Abstract][Full Text] [Related]
17. Measurement of antigen-specific IgE in nasal secretions of patients with perennial rhinitis.
Small P; Barrett D; Frenkiel S; Rochon L; Cohen C; Black M
Ann Allergy; 1985 Jul; 55(1):68-71. PubMed ID: 2409851
[TBL] [Abstract][Full Text] [Related]
18. [Allergen immunotherapy with an immunochemically characterized grass pollen extract: change in follow-up sensitization parameters].
Collet M; Urbanek R
Klin Padiatr; 1989; 201(3):183-8. PubMed ID: 2739344
[TBL] [Abstract][Full Text] [Related]
19. [Recent studies on nasal allergy (VII). The changes of the serum IgE level and specific IgE antibodies in patients with nasal allergy by hyposensitization therapy using mite (Dermatophagoides farinae) antigen (author's transl)].
Shimada T; Ishikawa T; Fujita Y; Miyashita H
Nihon Jibiinkoka Gakkai Kaiho; 1975 Jun; 78(6):519-27. PubMed ID: 1172529
[No Abstract] [Full Text] [Related]
20. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
